Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Kirsty Ratcliffe"'
Publikováno v:
BMJ Open, Vol 10, Iss 12 (2020)
Introduction Respiratory distress syndrome is a condition seen in preterm infants primarily due to surfactant insufficiency. European guidelines recommend the dose and method of surfactant administration. However, in routine practice, clinicians ofte
Externí odkaz:
https://doaj.org/article/8927ca8dc31341e3b8ac66c987f51a91
Autor:
Simon T. Barry, Stephen R. Wedge, Masabumi Shibuya, Juliane M. Jürgensmeier, Donald J. Ogilvie, Laurent Hennequin, Charles L. Farnsworth, Jeffrey C. Silva, Claire Barnes, Sian Taylor, Graham Sproat, Nicola Broadbent, Philippa Dudley, Jane Kendrew, Anna Wainwright, Sue Ashton, Neil H. James, Zena Wilson, Kirsty Ratcliffe, Sandra R. Brave
Supplementary Tables 1-3 from Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR Family
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b81f7c3e475189f7807aec38b527252
https://doi.org/10.1158/1535-7163.22496458.v1
https://doi.org/10.1158/1535-7163.22496458.v1
Autor:
Simon T. Barry, Stephen R. Wedge, Masabumi Shibuya, Juliane M. Jürgensmeier, Donald J. Ogilvie, Laurent Hennequin, Charles L. Farnsworth, Jeffrey C. Silva, Claire Barnes, Sian Taylor, Graham Sproat, Nicola Broadbent, Philippa Dudley, Jane Kendrew, Anna Wainwright, Sue Ashton, Neil H. James, Zena Wilson, Kirsty Ratcliffe, Sandra R. Brave
Supplementary Figure 1 from Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR Family
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e3cd5c5600a7c3ff0d61470189a4156
https://doi.org/10.1158/1535-7163.22496464
https://doi.org/10.1158/1535-7163.22496464
Autor:
Simon T. Barry, Stephen R. Wedge, Masabumi Shibuya, Juliane M. Jürgensmeier, Donald J. Ogilvie, Laurent Hennequin, Charles L. Farnsworth, Jeffrey C. Silva, Claire Barnes, Sian Taylor, Graham Sproat, Nicola Broadbent, Philippa Dudley, Jane Kendrew, Anna Wainwright, Sue Ashton, Neil H. James, Zena Wilson, Kirsty Ratcliffe, Sandra R. Brave
Cediranib is a potent inhibitor of the VEGF receptor (VEGFR)-2 and VEGFR-3 tyrosine kinases. This study assessed the activity of cediranib against the VEGFR-1 tyrosine kinase and the platelet-derived growth factor receptor (PDGFR)-associated kinases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c66c6430c693a5c3aeeab117ab20e0f
https://doi.org/10.1158/1535-7163.c.6535279
https://doi.org/10.1158/1535-7163.c.6535279
Autor:
Simon T. Barry, Stephen R. Wedge, Masabumi Shibuya, Juliane M. Jürgensmeier, Donald J. Ogilvie, Laurent Hennequin, Charles L. Farnsworth, Jeffrey C. Silva, Claire Barnes, Sian Taylor, Graham Sproat, Nicola Broadbent, Philippa Dudley, Jane Kendrew, Anna Wainwright, Sue Ashton, Neil H. James, Zena Wilson, Kirsty Ratcliffe, Sandra R. Brave
Supplementary Figure Legend from Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR Family
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::908f9c406205b7374b4c5f4dca4484fd
https://doi.org/10.1158/1535-7163.22496461
https://doi.org/10.1158/1535-7163.22496461
Autor:
Chris Womack, Juliane M. Jürgensmeier, Anderson Ryan, Neil Gray, Ruth Swann, Graham Sproat, Susan E. Ashton, Martin Jenkins, Kirsty Ratcliffe, Neil H. James, Dawn Baker, Neil R. Smith
Purpose: Vascular endothelial growth factor (VEGF) signaling is key to tumor angiogenesis and is an important target in the development of anticancer drugs. However, VEGF receptor (VEGFR) expression in human cancers, particularly the relative express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fc20ebb5ef55324f5bd484cd9e42d4a
https://doi.org/10.1158/1078-0432.c.6519125.v1
https://doi.org/10.1158/1078-0432.c.6519125.v1
Autor:
Chris Womack, Juliane M. Jürgensmeier, Anderson Ryan, Neil Gray, Ruth Swann, Graham Sproat, Susan E. Ashton, Martin Jenkins, Kirsty Ratcliffe, Neil H. James, Dawn Baker, Neil R. Smith
Supplementary Tables S1-S2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51e044ce9f2bed6f91aeaee21540d87e
https://doi.org/10.1158/1078-0432.22442387.v1
https://doi.org/10.1158/1078-0432.22442387.v1
Autor:
Kirsty Ratcliffe, Rachel Malone, Chris Gale, Kevin Colin William Goss, Nicholas T. Longford, Neena Modi
Publikováno v:
BMJ Open, Vol 10, Iss 12 (2020)
BMJ Open
BMJ Open
IntroductionRespiratory distress syndrome is a condition seen in preterm infants primarily due to surfactant insufficiency. European guidelines recommend the dose and method of surfactant administration. However, in routine practice, clinicians often
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd6744904b31be27a907b4515ea0417
https://bmjopen.bmj.com/content/10/12/e038959.full
https://bmjopen.bmj.com/content/10/12/e038959.full
Autor:
Ian Kimber, Catherine J. Betts, Richard A. Currie, Kirsty Ratcliffe, Fei Ling Lim, Rebecca J. Dearman
Publikováno v:
Toxicology. 226:45-46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df126b97d7aa72d1882e930cf25c678c
https://doi.org/10.1016/j.tox.2006.05.066
https://doi.org/10.1016/j.tox.2006.05.066
Autor:
Berg, Thomas1, Andreone, Pietro2, Pol, Stanislas3, Roberts, Stuart4, Younossi, Zobair5, Diago, Moises6, Lawitz, Eric J.7, Focaccia, Roberto8, Foster, Graham R.9, Horban, Andrzej10, Lonjon ‐ Domanec, Isabelle11, DeMasi, Ralph12, Picchio, Gaston12, Luo, Donghan12, De Meyer, Sandra13, Zeuzem, Stefan14
Publikováno v:
Liver International. Feb2015, Vol. 35 Issue 2, p448-454. 7p. 1 Diagram, 1 Chart, 2 Graphs.